CBP mediated DOT1L acetylation confers DOT1L stability and promotes cancer metastasis

Chaohua Liu, Qiaoyan Yang, Qian Zhu, Xiaopeng Lu, Meiting Li, Tianyun Hou, Zhiming Li, Ming Tang, Yinglu Li, Hui Wang,

Theranostics · 2020 · 64 citations · 54 references

DOIFull text

Open access

Concepts

Abstract

: DOT1L acetylation by CBP drives CRC progression and metastasis. Targeting DOT1L deacetylation signaling is a potential therapeutic strategy for DOT1L-driven cancers.

References

54